DaVita HealthCare Partners Inc.
http://www.davita.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From DaVita HealthCare Partners Inc.
Global Top 10 Medtechs Swap Places After Latest Quarterlies
Abbott Laboratories moved above Medtronic in MAT medtech revenues, while Philips Healthcare and Stryker finished 2022 with strong quarters, and Roche dropped a few places.
Will Epoetin Biosimilar Serve As Non-Medical Switching Case Study?
Analysts expect potential broad uptake of biosimilars in chronic kidney disease treated at dialysis centers, which could lead to patients being switched off Amgen's Epogen.
Will Epoetin Biosimilar Serve As Non-Medical Switching Case Study?
Analysts expect potential broad uptake of biosimilars in chronic kidney disease treated at dialysis centers, which could lead to patients being switched off Amgen's Epogen.
Amgen’s Repatha Passes CVOT Test, But Contribution To 2017 Sales Growth Unclear
Amgen’s PCSK9 inhibitor Repatha succeeded in the FOURIER cardiovascular outcomes study, but the data may not impact the company’s revenue until 2018 – after a potential revenue decline in 2017.
Company Information
- Industry
- Medical Devices
- Services
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice